Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Medivir announces first patient enrolled in FLEX-HCC study
Regulatory Filings Classification · 65% confidence The document is a corporate press release announcing clinical trial enrollment (FLEX-HCC study), with no financial results, management changes, governance details, or investor presentation materials. It does not fit any specific category such as earnings release, capital update, M&A, or interim report. It is a general regulatory announcement required under EU Market Abuse Regulation, so it falls under the fallback category for miscellaneous regulatory filings.
2026-05-21 English
Medivir meddelar att första patienten har inkluderats i FLEX-HCC-studien
Regulatory Filings Classification · 80% confidence The document is a corporate press release announcing the inclusion of the first patient in a Phase 2 clinical trial. It contains no financial statements, no earnings or management changes, and is not presenting any formal report. It is a mandatory disclosure under EU Market Abuse Regulation, fitting the “Regulatory Filings” fallback category for miscellaneous announcements. Therefore, it should be classified as RNS.
2026-05-21 Swedish
Resolutions at the Annual General Meeting in Medivir on 7 May 2026
Regulatory Filings
2026-05-07 English
Beslut vid årsstämma i Medivir den 7 maj 2026
Regulatory Filings
2026-05-07 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Delårsrapport januari – mars 2026' which translates to 'Interim Report January – March 2026'. It contains detailed financial data for the quarter, including revenue, EBITDA, cash flow, and cash position. It also discusses significant events during the quarter such as changes in the board, a directed share issue, clinical study updates, and management appointments. The document includes management commentary ('Vd har ordet'), detailed project pipeline updates, clinical trial phases, and financial summaries. The length is substantial (15,000 characters) and contains substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not an announcement of a report, nor a certification or a brief summary. Therefore, the correct classification is IR with high confidence.
2026-05-05 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Medivir AB – Interim Report January – March 2026' and contains detailed financial data for the quarter, including net turnover, EBITDA, earnings per share, cash flow, and cash position. It also discusses significant events during the quarter such as board changes, share issues, clinical study updates, and management appointments. The document includes a CEO's message, detailed descriptions of proprietary projects, clinical study phases, and results. The content is comprehensive and covers a period shorter than a full fiscal year (a quarter). It contains substantive financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-05-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.